Related Experiment Videos
[Neurotoxicity with cytostatic therapy: a review]
Schweizerische Medizinische Wochenschrift
|August 26, 1989
Summary
High-dose chemotherapy is increasingly used for cancer treatment. Recognizing chemotherapy-induced neurotoxicity early is crucial to prevent permanent neurological damage and manage side effects.
Area of Science:
- Oncology
- Neuroscience
- Pharmacology
Context:
- Cancer treatment increasingly utilizes high-dose chemotherapy for curative intent.
- Modern supportive therapies effectively manage dose-limiting hematological toxicities.
- Non-hematological toxicities, particularly neurotoxicity, are emerging as critical dose-limiting factors.
Purpose:
- To review the neurological side effects associated with cytostatic drugs.
- To emphasize the importance of early recognition of drug-induced neurological disturbances.
- To prevent irreversible neurological damage in cancer patients undergoing chemotherapy.
Summary:
- Neurotoxicity is a growing concern in cancer patient management.
- As hematological toxicities are better controlled, neurotoxicity becomes a more frequent dose-limiting factor.
- Early identification of chemotherapy-induced neurological disturbances is essential to avoid disabling side effects.
Impact:
- Facilitates safer administration of high-dose chemotherapy.
- Improves patient outcomes by mitigating severe neurological complications.
- Enhances the management of cancer patients by addressing non-hematological toxicities.